Award
Delivery Order #SPE2D226F1441
Delivery Order for Lisinopril Tablets Under IDV to DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$3.32
Ceiling
$3.32
Awarded
March 05, 2026
Period of Performance
Mar 05, 2026 – Mar 05, 2026
Identifier
SPE2D226F1441
NAICS
325411
This is a delivery order contract awarded to DMS Pharmaceutical Group Inc., a recognized pharmaceutical manufacturer and distributor, for the supply of lisinopril tablets. The contract is a part of a larger indefinite delivery vehicle (IDV) agreement aimed at providing essential pharmaceutical products to government healthcare agencies. The significance of this award lies in its role in maintaining the steady availability of critical medications, which is vital for governmental public health initiatives. The scope of work covers the procurement and delivery of lisinopril tablets to a specified location, ensuring timely access to this important medication. This award follows a competitive bidding process under the umbrella of the existing IDV contract with DMS Pharmaceutical Group, highlighting a sustained commitment to pharmaceutical supply continuity. The delivery order specifies a single-day performance period, indicating a focused and immediate fulfillment of the requirement.
Description
8511959770!LISINOPRIL TABLETS,